leisure time -WSS

leisure time

author：knowledge 2025-09-30 21:57:51 - browse：82

Two boxes of Ozempic stack on each other, while one lean on the stack tilted — health coverage from STAT — SEBASTIEN BOZON/AFP via Getty Images

Novo Nordisk’s Ozempic cut the risk of death in a trial of patients with type 2 diabetes and chronic kidney disease, suggesting it may offer some added benefits over other classes of drugs approved to treat this population.

Specifically, the diabetes drug cut the risk of cardiovascular-related deaths by 29% and all-cause deaths by 20%. Given the study parameters, this implies that over three years, 39 people would need to be treated to prevent one death from any cause, according to new results presented Friday at a meeting of the European Renal Association and published in the New England Journal of Medicine.

Ozempic also lowered the risk of major heart complications — including cardiovascular-related death, heart attack, or stroke — by 18%, driven primarily by the reduced rate of heart-linked death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： FDA authorizes Novavax’s updated Covid

knowledge

WSS

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Scientists find bacteria from stomach of ancient iceman

3 questions for the future of Biden's cancer moonshot

Sana to lay off nearly a third of staff, de

Medical schools are missing the mark on artificial intelligence

When women are denied an abortion, their children fare worse than peers

leisure time

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Bill would stop addiction treatment from triggering child abuse inquiry

Supreme Court strikes down use of affirmative action

When women are denied an abortion, their children fare worse than peers

Medical leaders decry Supreme Court decision on affirmative action

What to expect at HLTH 2023, the health care industry conference

Moonlake's readout produced a cash windfall. Risks remain

Bill would stop addiction treatment from triggering child abuse inquiry

Peter Hotez and the public health issue of online harassment

Bristol 'take

hotspot

A virus, fished out of a lake, may have saved a man’s life

Bristol 'take

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Liquid biopsy for lung cancer is launched by Delfi

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Wikipedia

focus

knowledge

focus